Proof of Usefulness Report

Peter Moss Leukaemia MedTech Research CIC

Analysis completed on 2/12/2026

+68
Proof of Usefulness Score
You're In Business

The project represents a legitimate UK Community Interest Company (CIC) dedicated to open-source Leukaemia research using AI and IoT, established in memory of Peter Moss. While the mission has high societal utility and the organization has verified partnerships (e.g., Intel Software Innovators), the submission quality is critically low. The claim that 'most people have used my product' is demonstrably false for a niche medical research initiative, and the 'marketcap' figure is ambiguous. The score reflects the strong ethical mission and technical legitimacy, heavily penalized for exaggerated traction claims and poor submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+27.6
Audience Reach Impact+5.6
Technical Innovation+10.8
Evidence Of Traction+7.9
Market Timing Relevance+8.0
Functional Completeness+0.5
Subtotal+60.4
Usefulness Multiplierx1.13
Final Score+68

Project Details

Description
Peter Moss Leukaemia MedTech Research CIC is a UK Community Interest Company, limited by guarantee and regulated by the C.I.C. Regulator. Company number: 13748398. In loving memory of Peter Edward Moss, 5th Aug 1939 - 24th Aug 2019, who bravely battled Acute Myeloid Leukaemia. A loving husband, father, grandfather and great grandfather. We are a group of volunteers whose mission it is to defeat Leukaemia with technology, and bring down the cost of medical care. We are dedicated to researching into the latest Artificial Intelligence, Internet Of Things and other modern technologies, and how they can be used in the fight against Leukaemia and other blood diseases. Our mission, since 2018, is to advance Leukemia medical research and technologies. We aim to ensure our research, findings, and technologies remain free to anyone that can benefit from their use and are willing to share their contributions back to the community. We bring together individuals, companies and organizations to create innovative technologies that can be used in the fight against leukemia and other cancers, and to help bring down the cost of treatment for patients. We are building a network of innovation and collaboration to provide a better future for people and society. We are creating an "open source" movement for leukemia & medical technology research. No patents, no proprietary data, no proprietary code. We want to change how the medical system works, and provide our research and technology open and free. In loving memory of Peter Edward Moss 5th Aug 1939 - 24th Aug 2019.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline